Financials
- Market Capitalization 2.48 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
13.24
市销率
2.13
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1622 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 6.89 USD | +6.33% | +25.73% | +15.60% | -47.72% | 3.41 B USD | ||
| 1848 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.53 USD | -1.00% | -0.02% | -7.46% | -19.39% | 2.53 B USD | ||
| 1867 | HCM HUTCHMED (China) Limited - American Depositary Shares | 14.09 USD | -0.14% | +13.26% | +22.10% | -13.45% | 2.46 B USD | ||
| 1869 | BHC Bausch Health Companies Inc. Common Stock | 6.56 USD | -2.96% | +3.14% | +3.31% | -10.38% | 2.45 B USD |